Stevens-Johnson syndrome (SJS) leading to resolution of mania.
Manu
M
Arora
Samir Kumar
SK
Praharaj
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects; D001714:Bipolar Disorder / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy / Q000379:methods; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D012720:Severity of Illness Index; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D002220:Carbamazepine; D008094:Lithium; D000077152:Olanzapine